BMJ Open (May 2024)

Impact evaluation of a cash-plus programme for children with disabilities in the Xiengkhouang Province in Lao PDR: study protocol for a non-randomised controlled trial

  • Hannah Kuper,
  • Shanquan Chen,
  • Calum Davey,
  • Tom Shakespeare,
  • Nathaniel Scherer,
  • Bounhome Soukkhaphone,
  • Mark T Carew,
  • Latsamy Siengsounthone,
  • Lena Morgon Banks,
  • Divya Goyal,
  • Anja Zinke-Allmang,
  • Ketmany Chanthakoumane

DOI
https://doi.org/10.1136/bmjopen-2023-081536
Journal volume & issue
Vol. 14, no. 5

Abstract

Read online

Introduction More than 170 countries have implemented disability-targeted social protection programmes, although few have been rigorously evaluated. Consequently, a non-randomised controlled trial is being conducted of a pilot ‘cash-plus’ programme implemented by UNICEF Laos and the Laos government for children with disabilities in the Xiengkhouang Province in Laos. The intervention combines a regular cash transfer with provision of assistive devices and access for caregivers to a family support programme.Methods and analysis The non-randomised controlled trial will involve 350 children with disabilities across 3 districts identified by programme implementers as eligible for the programme (intervention arm). Implementers have also identified approximately 180 children with disabilities in neighbouring districts, who would otherwise meet eligibility criteria but do not live in the project areas (control arm). The trial will assess the impact of the programme on child well-being (primary outcome), as well as household poverty, caregiver quality of life and time use (secondary outcomes). Baseline data are being collected May–October 2023, with endline 24 months later. Analysis will be intention to treat. A complementary process evaluation will explore the implementation, acceptability of the programme, challenges and enablers to its delivery and mechanisms of impact.Ethics and dissemination The study has received ethical approval from the London School of Hygiene and Tropical Medicine and the National Ethics Committee for Health Research in Laos. Informed consent and assent will be taken by trained data collectors. Data will be collected and stored on a secure, encrypted server and its use will follow a detailed data management plan. Findings will be disseminated in academic journals and in short briefs for policy and programmatic actors, and in online and in-person events.Trial registration number ISRCTN80603476.